Thomas Jefferson University

Andrea Barrio

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentFaculty Records and Publicatio - Thomas Jefferson University
Address833 Chestnut Street
Philadelphia PA 19023
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Morrow M, Barrio AV. Is It Time to Abandon Surgery for Low-Risk DCIS? JAMA. 2025 Mar 18; 333(11):946-947. PMID: 39665591.
      Citations:    
    2. Roberts A, Campbell AC, Pollack BL, Montagna G, Sevilimedu V, Axelrod B, Gomez EA, Giri D, Morrow M, Mehrara BJ, Barrio AV. Racial and Ethnic Differences in Breast Inflammation and Its Association with Lymphedema Risk After Axillary Lymph Node Dissection. Ann Surg Oncol. 2025 May; 32(5):3309-3316. PMID: 39971857.
      Citations:    
    3. Campbell AC, Kuonqui KG, Ashokan G, Rubin J, Shin J, Pollack BL, Roberts A, Sarker A, Park HJ, Kataru RP, Barrio AV, Mehrara BJ. Role of inducible nitric oxide (iNOS) and nitrosative stress in regulating sex differences in secondary lymphedema. Front Physiol. 2024; 15:1510389. PMID: 39691094.
      Citations:    
    4. Singh P, Agnese DM, Amin M, Barrio AV, van den Bruele AB, Burke EE, Danforth DN, Dirbas FM, Eladoumikdachi F, Fayanju OM, Kantor O, Kumar S, Lee MC, Matsen C, Nguyen TT, Ozmen T, Park KU, Plichta JK, Reyna C, Showalter SL, Styblo T, Tranakas N, Weiss A, Woodfin A, Laronga C, Boughey JC. Society of Surgical Oncology Breast Disease Site Working Group Statement on Bilateral Risk-Reducing Mastectomy: Indications, Outcomes, and Risks. Ann Surg Oncol. 2025 Feb; 32(2):899-911. PMID: 39538100.
      Citations:    
    5. Montagna G, Laws A, Ferrucci M, Mrdutt MM, Sun SX, Bademler S, Balbaloglu H, Balint-Lahat N, Banys-Paluchowski M, Barrio AV, Benson J, Bese N, Boughey JC, Boyle MK, Diego EJ, Eden C, Eller R, Goldschmidt M, Hlavin C, Heidinger M, Jelinska J, Karadeniz Cakmak G, Kesmodel SB, King TA, Kuerer HM, Loesch J, Milardi F, Murawa D, Moo TA, Menes TS, Passeri D, Pastoriza JM, Perhavec A, Pislar N, Polidorio N, Rami A, Ryu JM, Schulz A, Sevilimedu V, Ugurlu MU, Uras C, van Hemert A, Wong SM, Yoo TR, Zhang JQ, Karanlik H, Cabioglu N, Peeters MV, Morrow M, Weber WP. Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study. J Clin Oncol. 2025 03; 43(7):810-820. PMID: 39509672.
      Citations:    
    6. Chew SM, Ferraro E, Chen Y, Barrio AV, Kelly D, Modi S, Seidman AD, Wen H, Brogi E, Robson M, Dang CT. Invasive disease-free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab. NPJ Breast Cancer. 2024 Oct 28; 10(1):96. PMID: 39468041.
      Citations:    
    7. Barrio AV, Morrow M, Mehrara BJ. Social Work's Role in Bridging Breast Cancer Care Gaps-Reply. JAMA Surg. 2024 Oct 01; 159(10):1221-1222. PMID: 39110438.
      Citations:    
    8. Barrio AV. Time to abandon axillary lymph node dissection in early-stage breast cancer. Lancet Oncol. 2024 09; 25(9):1111-1113. PMID: 39121880.
      Citations:    
    9. Myers SP, Sevilimedu V, Barrio AV, Tadros AB, Mamtani A, Robson ME, Morrow M, Lee MK. Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers. NPJ Breast Cancer. 2024 Jul 26; 10(1):63. PMID: 39060255.
      Citations:    
    10. Jones VM, Nelson JA, Sevilimedu V, Le T, Allen RJ, Mehrara BJ, Barrio AV, Capko DM, Heerdt AS, Tadros AB, Gemignani ML, Morrow M, Sacchini V, Moo TA. Impact of Mastectomy Flap Necrosis on Patient-Reported Quality-of-Life Measures After Nipple-Sparing Mastectomy: A Preliminary Analysis. Ann Surg Oncol. 2024 Oct; 31(10):6795-6803. PMID: 38990221.
      Citations:    
    11. Campbell AC, Baik JE, Sarker A, Brown S, Park HJ, Kuonqui KG, Shin J, Pollack BL, Roberts A, Ashokan G, Rubin J, Kataru RP, Dayan JH, Barrio AV, Mehrara BJ. Breast Cancer-Related Lymphedema Results in Impaired Epidermal Differentiation and Tight Junction Dysfunction. J Invest Dermatol. 2025 Jan; 145(1):85-97.e4. PMID: 38879154.
      Citations:    
    12. Heller DR, Axelrod B, Sevilimedu V, Morrow M, Mehrara BJ, Barrio AV. Quality of Life After Axillary Lymph Node Dissection Among Racial and Ethnic Minority Women. JAMA Surg. 2024 06 01; 159(6):668-676. PMID: 38536186.
      Citations:    
    13. Montagna G, Mrdutt MM, Sun SX, Hlavin C, Diego EJ, Wong SM, Barrio AV, van den Bruele AB, Cabioglu N, Sevilimedu V, Rosenberger LH, Hwang ES, Ingham A, Papassotiropoulos B, Nguyen-Str?uli BD, Kurzeder C, Aybar DD, Vorburger D, Matlac DM, Ostapenko E, Riedel F, Fitzal F, Meani F, Fick F, Sagasser J, Heil J, Karanlik H, Dedes KJ, Romics L, Banys-Paluchowski M, Muslumanoglu M, Perez MDRC, D?az MC, Heidinger M, Fehr MK, Reinisch M, Tukenmez M, Maggi N, Rocco N, Ditsch N, Gentilini OD, Paulinelli RR, Zarhi SS, Kuemmel S, Bruzas S, di Lascio S, Parissenti TK, Hoskin TL, G?th U, Ovalle V, Tausch C, Kuerer HM, Caudle AS, Boileau JF, Boughey JC, K?hn T, Morrow M, Weber WP. Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy. JAMA Oncol. 2024 06 01; 10(6):793-798. PMID: 38662396.
      Citations:    
    14. Pawloski KR, Barrio AV. Breast surgery after neoadjuvant systemic therapy. Transl Breast Cancer Res. 2024; 5:13. PMID: 38751679.
      Citations:    
    15. Singh P, Agnese D, Amin M, Barrio AV, Botty Van den Bruele A, Burke E, Danforth DN, Dirbas FM, Eladoumikdachi F, Kantor O, Kumar S, Lee MC, Matsen C, Nguyen TT, Ozmen T, Park KU, Plichta JK, Reyna C, Showalter SL, Styblo T, Tranakas N, Weiss A, Laronga C, Boughey J. Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks. Ann Surg Oncol. 2024 Apr; 31(4):2212-2223. PMID: 38261126.
      Citations:    
    16. Myers SP, Sevilimedu V, Barrio AV, Tadros AB, Mamtani A, Robson ME, Morrow M, Lee MK. Mutational Status is Associated with a Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer. Ann Surg Oncol. 2023 Dec; 30(13):8412-8418. PMID: 37798552.
      Citations:    
    17. Rochlin DH, Barrio AV, McLaughlin S, Van Zee KJ, Woods JF, Dayan JH, Coriddi MR, McGrath LA, Bloomfield EA, Boe L, Mehrara BJ. Feasibility and Clinical Utility of Prediction Models for Breast Cancer-Related Lymphedema Incorporating Racial Differences in Disease Incidence. JAMA Surg. 2023 09 01; 158(9):954-964. PMID: 37436762.
      Citations:    
    18. Montagna G, Barrio AV. Managing the Morbidity: Individualizing Risk Assessment, Diagnosis, and Treatment Options for Upper Extremity Lymphedema. Surg Oncol Clin N Am. 2023 10; 32(4):705-724. PMID: 37714638.
      Citations:    
    19. Moo TA, Nelson JA, Sevilimedu V, Charyn J, Le TV, Allen RJ, Mehrara BJ, Barrio AV, Capko DM, Pilewskie M, Heerdt AS, Tadros AB, Gemignani ML, Morrow M, Sacchini V. Strategies to avoid mastectomy skin-flap necrosis during nipple-sparing mastectomy. Br J Surg. 2023 06 12; 110(7):831-838. PMID: 37178195.
      Citations:    
    20. Zhang YH, Montagna G, Flynn J, Gillespie EF, Mamtani A, Zhang Z, Braunstein LZ, Powell SN, Morrow M, Barrio A, Khan AJ. Outcomes of Breast Cancer Patients with High Volume of Residual Disease Following Neoadjuvant Chemotherapy. Int J Radiat Oncol Biol Phys. 2023 03 01; 115(3):622-628. PMID: 36155213.
      Citations:    
    21. Williams AD, Khan AJ, Sevilimedu V, Barrio AV, Morrow M, Mamtani A. Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy. Ann Surg Oncol. 2022 Dec; 29(13):8037-8043. PMID: 35951137.
      Citations:    
    22. Williams AD, Barrio AV. ASO Author Reflections: Is It Worth the Risk? The Benefit of Neoadjuvant Chemotherapy in Elderly Patients with Breast Cancer. Ann Surg Oncol. 2022 12; 29(13):8012-8013. PMID: 35941345.
      Citations:    
    23. Montagna G, Zhang J, Sevilimedu V, Charyn J, Abbate K, Gomez EA, Mehrara B, Morrow M, Barrio AV. Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer-Related Lymphedema. JAMA Oncol. 2022 08 01; 8(8):1195-1200. PMID: 35679026.
      Citations:    
    24. Montagna G, Lee MK, Sevilimedu V, Barrio AV, Morrow M. Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy? Ann Surg Oncol. 2022 Oct; 29(10):6133-6139. PMID: 35902495.
      Citations:    
    25. Williams AD, Dang CT, Sevilimedu V, Morrow M, Barrio AV. Neoadjuvant Chemotherapy for Breast Cancer In the Elderly: Are We Accomplishing Our Treatment Goals? Ann Surg Oncol. 2022 Dec; 29(13):8002-8011. PMID: 35871672.
      Citations:    
    26. Barrio AV, Montagna G, Morrow M. Is Regional Nodal Radiotherapy Necessary for Patients With cN1 and ypN0 Breast Cancer After Neoadjuvant Chemotherapy?-Reply. JAMA Oncol. 2022 06 01; 8(6):1. PMID: 35551361.
      Citations:    
    27. Zhang JQ, Barrio AV. ASO Author Reflections: Acute or Chronic? The Effect of Axillary Lymph Node Dissection on Arm Symptoms and Quality of Life Over Time. Ann Surg Oncol. 2022 Apr 18. PMID: 35435563.
      Citations:    
    28. Zhang JQ, Montagna G, Sevilimedu V, Abbate K, Charyn J, Mehrara B, Morrow M, Barrio AV. Longitudinal Prospective Evaluation of Quality of Life After Axillary Lymph Node Dissection. Ann Surg Oncol. 2022 Apr 01. PMID: 35364766.
      Citations:    
    29. Ferraro E, Singh J, Patil S, Razavi P, Modi S, Chandarlapaty S, Barrio AV, Malani R, Mellinghoff IK, Boire A, Wen HY, Brogi E, Seidman AD, Norton L, Robson ME, Dang CT. Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab. NPJ Breast Cancer. 2022 Mar 22; 8(1):37. PMID: 35319017.
      Citations:    
    30. Verdial FC, Mamtani A, Pawloski KR, Sevilimedu V, D'Alfonso TM, Zhang H, Gemignani ML, Barrio AV, Morrow M, Tadros AB. The Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg Oncol. 2022 Jun; 29(6):3810-3819. PMID: 35246810.
      Citations:    
    31. Matar R, Barrio AV, Sevilimedu V, Le T, Heerdt A, Morrow M, Tadros A. Can We Successfully De-Escalate Axillary Surgery in Women Aged = 70 Years with Ductal Carcinoma in Situ or Early-Stage Breast Cancer Undergoing Mastectomy? Ann Surg Oncol. 2022 Apr; 29(4):2263-2272. PMID: 34994896.
      Citations:    
    32. Oskar S, Nelson JA, Hicks MEV, Seier M S KP, Tan KS, Chu JJ, West S, Allen RJ, Barrio AV, Matros E, Afonso AM. The Impact of Race on Perioperative and Patient-Reported Outcomes following Autologous Breast Reconstruction. Plast Reconstr Surg. 2022 Jan 01; 149(1):15-27. PMID: 34936598.
      Citations:    
    33. Barrio AV, Montagna G, Mamtani A, Sevilimedu V, Edelweiss M, Capko D, Cody HS, El-Tamer M, Gemignani ML, Heerdt A, Kirstein L, Moo TA, Pilewskie M, Plitas G, Sacchini V, Sclafani L, Tadros A, Van Zee KJ, Morrow M. Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare Event. JAMA Oncol. 2021 Dec 01; 7(12):1851-1855. PMID: 34617979.
      Citations:    
    34. Mamtani A, Sevilimedu V, Le T, Morrow M, Barrio AV. Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy? Cancer. 2022 02 01; 128(3):471-478. PMID: 34597420.
      Citations:    
    35. Mrdutt M, Heerdt A, Sevilimedu V, Mamtani A, Barrio A, Morrow M. Margin Width and Local Recurrence in Patients Undergoing Breast Conservation After Neoadjuvant Chemotherapy. Ann Surg Oncol. 2022 Jan; 29(1):484-492. PMID: 34331159.
      Citations:    
    36. Coriddi M, Kim L, McGrath L, Encarnacion E, Brereton N, Shen Y, Barrio AV, Mehrara B, Dayan JH. Accuracy, Sensitivity, and Specificity of the LLIS and ULL27 in Detecting Breast Cancer-Related Lymphedema. Ann Surg Oncol. 2022 Jan; 29(1):438-445. PMID: 34264409.
      Citations:    
    37. Pawloski KR, Barrio AV, Gemignani ML, Sevilimedu V, Le T, Dayan J, Morrow M, Tadros AB. Reconstruction in Women with T4 Breast Cancer after Neoadjuvant Chemotherapy: When Is It Safe? J Am Coll Surg. 2021 08; 233(2):285-293. PMID: 33957258.
      Citations:    
    38. Moo TA, Pawloski KR, Flynn J, Edelweiss M, Le T, Tadros A, Barrio AV, Morrow M. Is Residual Nodal Disease at Axillary Dissection Associated with Tumor Subtype in Patients with Low Volume Sentinel Node Metastasis After Neoadjuvant Chemotherapy? Ann Surg Oncol. 2021 Oct; 28(11):6044-6050. PMID: 33876362.
      Citations:    
    39. Brunelle CL, Barrio AV, Taghian AG. Letter to editor re: Shah et al.: "The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements". Breast Cancer Res Treat. 2021 02; 186(1):271-272. PMID: 33630194.
      Citations:    
    40. Moo TA, Edelweiss M, Hajiyeva S, Stempel M, Raiss M, Zabor EC, Barrio AV, Morrow M. Correction to: Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? Ann Surg Oncol. 2020 Dec; 27(Suppl 3):966. PMID: 32086652.
      Citations:    
    41. Moo TA, Pawloski KR, Sevilimedu V, Charyn J, Simon BA, Sclafani LM, Plitas G, Barrio AV, Kirstein LJ, Van Zee KJ, Morrow M. Changing the Default: A Prospective Study of Reducing Discharge Opioid Prescription after Lumpectomy and Sentinel Node Biopsy. Ann Surg Oncol. 2020 Nov; 27(12):4637-4642. PMID: 32734370.
      Citations:    
    42. Petruolo O, Sevilimedu V, Montagna G, Le T, Morrow M, Barrio AV. How Often Does Modern Neoadjuvant Chemotherapy Downstage Patients to Breast-Conserving Surgery? Ann Surg Oncol. 2021 Jan; 28(1):287-294. PMID: 32514804.
      Citations:    
    43. Montagna G, Mamtani A, Knezevic A, Brogi E, Barrio AV, Morrow M. Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant Chemotherapy. Ann Surg Oncol. 2020 Oct; 27(11):4515-4522. PMID: 32488513.
      Citations:    
    44. Mamtani A, Barrio AV, Goldman DA, Wen HY, Vincent A, Morrow M. Extranodal Tumor Deposits in the Axillary Fat Indicate the Need for Axillary Dissection Among T1-T2cN0 Patients with Positive Sentinel Nodes. Ann Surg Oncol. 2020 Oct; 27(10):3585-3592. PMID: 32488512.
      Citations:    
    45. Petruolo O, Barrio AV. ASO Author Reflections: Avoiding Mastectomy: The Benefit of Neoadjuvant Chemotherapy for Large Unifocal Breast Tumors. Ann Surg Oncol. 2020 Dec; 27(Suppl 3):755-756. PMID: 32444911.
      Citations:    
    46. Barrio AV, Morrow M. ASO Author Reflections: To Dissect or Not to Dissect-The Clinical Implications of Microscopic Extracapsular Extension in the Sentinel Node. Ann Surg Oncol. 2020 May; 27(5):1625-1626. PMID: 32052300.
      Citations:    
    47. Barrio AV, Downs-Canner S, Edelweiss M, Van Zee KJ, Cody HS, Gemignani ML, Pilewskie ML, Plitas G, El-Tamer M, Kirstein L, Capko D, Patil S, Morrow M. Microscopic Extracapsular Extension in Sentinel Lymph Nodes Does Not Mandate Axillary Dissection in Z0011-Eligible Patients. Ann Surg Oncol. 2020 May; 27(5):1617-1624. PMID: 31820212.
      Citations:    
    48. Grabenstetter A, Moo TA, Hajiyeva S, Sch?ffler PJ, Khattar P, Friedlander MA, McCormack MA, Raiss M, Zabor EC, Barrio A, Morrow M, Edelweiss M. Accuracy of Intraoperative Frozen Section of Sentinel Lymph Nodes After Neoadjuvant Chemotherapy for Breast Carcinoma. Am J Surg Pathol. 2019 10; 43(10):1377-1383. PMID: 31219817.
      Citations:    
    49. Barrio AV, Brunelle C, Morrow M, Taghian AG. Letter to Editor re: Ridner et al.: "A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis". Ann Surg Oncol. 2019 12; 26(Suppl 3):863-864. PMID: 31468217.
      Citations:    
    50. Barrio AV, Van Zee KJ. Ductal Carcinoma In Situ of the Breast: Controversies and Current Management. Adv Surg. 2019 09; 53:21-35. PMID: 31327448.
      Citations:    
    51. Spanheimer PM, Barrio AV. ASO Author Reflections: Malignant/Borderline Phyllodes Tumors Without Uniformly Poor Histologic Features Have an Excellent Prognosis. Ann Surg Oncol. 2019 12; 26(Suppl 3):619-620. PMID: 31111350.
      Citations:    
    52. Spanheimer PM, Murray MP, Zabor EC, Stempel M, Morrow M, Van Zee KJ, Barrio AV. Long-Term Outcomes After Surgical Treatment of Malignant/Borderline Phyllodes Tumors of the Breast. Ann Surg Oncol. 2019 Jul; 26(7):2136-2143. PMID: 30783853.
      Citations:    
    53. Romanoff A, Zabor EC, Petruolo O, Stempel M, El-Tamer M, Morrow M, Barrio AV. Does nonmetastatic inflammatory breast cancer have a worse prognosis than other nonmetastatic T4 cancers? Cancer. 2018 11 15; 124(22):4314-4321. PMID: 30307616.
      Citations:    
    54. Brunelle CL, Barrio AV, Shaitelman SF, Singhal D, Sayegh HE, Taghian AG. On "Diagnosis of Upper Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline from the Oncology Section of the American Physical Therapy Association." Levenhagen K, Davies C, Perdomo M, Ryans K, Gilchrist L. Phys Ther. 2017;97:729-745. Phys Ther. 2018 04 01; 98(4):277-281. PMID: 29617972.
      Citations:    
    55. Moo TA, Edelweiss M, Hajiyeva S, Stempel M, Raiss M, Zabor EC, Barrio A, Morrow M. Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? Ann Surg Oncol. 2018 Jun; 25(6):1488-1494. PMID: 29572705.
      Citations:    
    56. Weber JJ, Jochelson MS, Eaton A, Zabor EC, Barrio AV, Gemignani ML, Pilewskie M, Van Zee KJ, Morrow M, El-Tamer M. MRI and Prediction of Pathologic Complete Response in the Breast and Axilla after Neoadjuvant Chemotherapy for Breast Cancer. J Am Coll Surg. 2017 Dec; 225(6):740-746. PMID: 28919579.
      Citations:    
    57. Gentile LF, Plitas G, Zabor EC, Stempel M, Morrow M, Barrio AV. Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer. Ann Surg Oncol. 2017 Dec; 24(13):3896-3902. PMID: 28916978.
      Citations:    
    58. Morrow M, Van Zee KJ, Patil S, Petruolo O, Mamtani A, Barrio AV, Capko D, El-Tamer M, Gemignani ML, Heerdt AS, Kirstein L, Pilewskie M, Plitas G, Sacchini VS, Sclafani LM, Ho A, Cody HS. Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers: A Prospective Validation Study of 793 Patients. Ann Surg. 2017 09; 266(3):457-462. PMID: 28650355.
      Citations:    
    59. Muhsen S, Barrio AV, Miller M, Olcese C, Patil S, Morrow M, Van Zee KJ. Outcomes for Women with Minimal-Volume Ductal Carcinoma In Situ Completely Excised at Core Biopsy. Ann Surg Oncol. 2017 Dec; 24(13):3888-3895. PMID: 28828599.
      Citations:    
    60. Pilewskie M, Zabor EC, Mamtani A, Barrio AV, Stempel M, Morrow M. The Optimal Treatment Plan to Avoid Axillary Lymph Node Dissection in Early-Stage Breast Cancer Patients Differs by Surgical Strategy and Tumor Subtype. Ann Surg Oncol. 2017 Nov; 24(12):3527-3533. PMID: 28762114.
      Citations:    
    61. Petruolo OA, Pilewskie M, Patil S, Barrio AV, Stempel M, Wen HY, Morrow M. Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant Chemotherapy. Ann Surg Oncol. 2017 Sep; 24(9):2556-2562. PMID: 28560596.
      Citations:    
    62. Singh JC, Mamtani A, Barrio A, Morrow M, Sugarman S, Jones LW, Yu AF, Argolo D, Smyth LM, Modi S, Schweber S, Boafo C, Patil S, Norton L, Baselga J, Hudis CA, Dang C. Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2-Positive Early Stage Breast Cancer: A Single Center Experience. Oncologist. 2017 02; 22(2):139-143. PMID: 28167568.
      Citations:    
    63. Barrio AV, Mamtani A, Eaton A, Brennan S, Stempel M, Morrow M. Is Routine Axillary Imaging Necessary in Clinically Node-Negative Patients Undergoing Neoadjuvant Chemotherapy? Ann Surg Oncol. 2017 Mar; 24(3):645-651. PMID: 28130619.
      Citations:    
    64. Barrio AV, Van Zee KJ. Controversies in the Treatment of Ductal Carcinoma in Situ. Annu Rev Med. 2017 01 14; 68:197-211. PMID: 28099081.
      Citations:    
    65. Tuttle TM, Barrio AV, Klimberg VS, Giuliano AE, Chavez-MacGregor M, Buum HA, McMasters KM. Guidelines for Guidelines: An Assessment of the American Society of Breast Surgeons Contralateral Prophylactic Mastectomy Consensus Statement. Ann Surg Oncol. 2017 Jan; 24(1):1-2. PMID: 27783164.
      Citations:    
    66. Barrio AV, Mamtani A, Edelweiss M, Eaton A, Stempel M, Murray MP, Morrow M. How Often Is Treatment Effect?Identified in Axillary Nodes with a Pathologic Complete Response After Neoadjuvant Chemotherapy? Ann Surg Oncol. 2016 10; 23(11):3475-3480. PMID: 27469123.
      Citations:    
    67. Mamtani A, Patil S, Van Zee KJ, Cody HS, Pilewskie M, Barrio AV, Heerdt AS, Morrow M. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases. Ann Surg Oncol. 2016 10; 23(11):3481-3486. PMID: 27169771.
      Citations:    
    68. Mamtani A, Barrio AV, King TA, Van Zee KJ, Plitas G, Pilewskie M, El-Tamer M, Gemignani ML, Heerdt AS, Sclafani LM, Sacchini V, Cody HS, Patil S, Morrow M. How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study. Ann Surg Oncol. 2016 10; 23(11):3467-3474. PMID: 27160528.
      Citations:    
    69. Barrio AV, Morrow M. Appropriate margin for lumpectomy excision of invasive breast cancer. Chin Clin Oncol. 2016 Jun; 5(3):35. PMID: 27164854.
      Citations:    
    70. Van Zee KJ, Barrio AV, Tchou J. Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ. JAMA Oncol. 2016 Mar; 2(3):397-8. PMID: 26967180.
      Citations:    
    71. Bloomquist EV, Ajkay N, Patil S, Collett AE, Frazier TG, Barrio AV. A Randomized Prospective Comparison of Patient-Assessed Satisfaction and Clinical Outcomes with Radioactive Seed Localization versus Wire Localization. Breast J. 2016 Mar-Apr; 22(2):151-7. PMID: 26696461.
      Citations:    
    72. Ajkay N, Bloomquist EV, Martin RC, Frazier TG, Barrio AV. Fine-needle aspiration cytology in the evaluation of patients with radiographically occult, palpable breast abnormalities. Surgery. 2015 Oct; 158(4):946-52; discussion 952-3. PMID: 26283205.
      Citations:    
    73. Barrio AV, Eaton A, Frazier TG. A Prospective Validation Study of Bioimpedance with Volume Displacement in Early-Stage Breast Cancer Patients at Risk for Lymphedema. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S370-5. PMID: 26085222.
      Citations:    
    74. Ajkay N, Collett AE, Bloomquist EV, Gracely EJ, Frazier TG, Barrio AV. A comparison of complication rates in early-stage breast cancer patients treated with brachytherapy versus whole-breast irradiation. Ann Surg Oncol. 2015 Apr; 22(4):1140-5. PMID: 25319575.
      Citations:    
    75. Collett AE, Guilfoyle C, Gracely EJ, Frazier TG, Barrio AV. Infrared imaging does not predict the presence of malignancy in patients with suspicious radiologic breast abnormalities. Breast J. 2014 Jul-Aug; 20(4):375-80. PMID: 24861444.
      Citations:    
    76. Van Zee KJ, Hansen NM, Barrio AV, Connor CS, Danforth DN, Euhus DM, Kulkarni SA, McCready DR, McLaughlin S, Wilke LG. Commentary on the Canadian National Breast Screening study. Ann Surg Oncol. 2014 Dec; 21(13):4397-8. PMID: 24859935.
      Citations:    
    77. Guilfoyle C, Christoudias M, Collett AE, Gracely EJ, Frazier TG, Barrio AV. Effect of preoperative MRI on mastectomy and contralateral prophylactic mastectomy rates at a community hospital by a single surgeon. Breast J. 2014 Jan-Feb; 20(1):79-83. PMID: 24438066.
      Citations:    
    78. Christoudias MK, Collett AE, Stull TS, Gracely EJ, Frazier TG, Barrio AV. Are the American Society for Radiation Oncology guidelines accurate predictors of recurrence in early stage breast cancer patients treated with balloon-based brachytherapy? Int J Surg Oncol. 2013; 2013:829050. PMID: 24382996.
      Citations:    
    79. Manjoros DT, Collett AE, Alberty-Oller JJ, Frazier TG, Barrio AV. The value of 6-month interval imaging after benign radiologic-pathologic concordant minimally invasive breast biopsy. Ann Surg Oncol. 2013 Oct; 20(10):3163-8. PMID: 23975288.
      Citations:    
    80. Stull TS, Catherine Goodwin M, Gracely EJ, Chernick MR, Carella RJ, Frazier TG, Barrio AV. A single-institution review of accelerated partial breast irradiation in patients considered "cautionary" by the American Society for Radiation Oncology. Ann Surg Oncol. 2012 Feb; 19(2):553-9. PMID: 21769461.
      Citations:    
    81. Allen LR, Lago-Toro CE, Hughes JH, Careaga E, Brown AT, Chernick M, Barrio AV, Frazier TG. Is there a role for MRI in the preoperative assessment of patients with DCIS? Ann Surg Oncol. 2010 Sep; 17(9):2395-400. PMID: 20217259.
      Citations:    
    82. Wagner PL, Eachempati S, Barrio A, Muir JC, Wang JC, Barie PS. Use of continuous venovenous haemodialysis to reverse acute hypothermia after multiple trauma. Asian J Surg. 2008 Jul; 31(3):151-3. PMID: 18658015.
      Citations:    
    83. Barrio AV, Clark BD, Goldberg JI, Hoque LW, Bernik SF, Flynn LW, Susnik B, Giri D, Polo K, Patil S, Van Zee KJ. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol. 2007 Oct; 14(10):2961-70. PMID: 17562113.
      Citations:    
    Barrio's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (178)
    Explore
    _
    Co-Authors (1)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _